Morgan Stanley Raises Price Target for Philip Morris on Zyn and IQOS Growth
On June 3, Morgan Stanley raised its price target for Philip Morris International (PM) to $200 from $190 while maintaining an Overweight rating. The upgrade follows updates at a recent investor conference about the launch of Zyn Ultra in the U.S. and progress on IQOS in Japan.
Topics: Dividend Stocks IQOS Morgan Stanley Philip Morris Zyn